F-Star GmbH, the Austrian antibody engineering firm, has raised €15 million from a syndicate of venture capital firms led by SR-One. Other participants were Atlas Venture, Aescap Venture, Novo Ventures, TVM Capital, Merck Serono Ventures and MP Healthcare.
